WO2003012104A1 - Novel g protein-coupled receptor protein and dna thereof - Google Patents

Novel g protein-coupled receptor protein and dna thereof Download PDF

Info

Publication number
WO2003012104A1
WO2003012104A1 PCT/JP2002/007773 JP0207773W WO03012104A1 WO 2003012104 A1 WO2003012104 A1 WO 2003012104A1 JP 0207773 W JP0207773 W JP 0207773W WO 03012104 A1 WO03012104 A1 WO 03012104A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
novel
dna
coupled receptor
screening
Prior art date
Application number
PCT/JP2002/007773
Other languages
French (fr)
Japanese (ja)
Inventor
Shuji Sato
Yasushi Shintani
Nobuyuki Miyajima
Original Assignee
Takeda Chemical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries, Ltd. filed Critical Takeda Chemical Industries, Ltd.
Publication of WO2003012104A1 publication Critical patent/WO2003012104A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

It is intended to provide a novel protein which is useful in screening an agonist/an antagonist, etc. More specifically, a human-origin protein or its salt; a DNA encoding this protein; a method of determining a ligand to this protein; a method/a kit for screening a compound capable of altering the binding properties of the ligand to the protein; compounds obtained by the screening or salts thereof; and so on.
PCT/JP2002/007773 2001-08-01 2002-07-31 Novel g protein-coupled receptor protein and dna thereof WO2003012104A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001-234295 2001-08-01
JP2001234295A JP2003047472A (en) 2001-08-01 2001-08-01 New g protein conjugated receptor protein and its dna

Publications (1)

Publication Number Publication Date
WO2003012104A1 true WO2003012104A1 (en) 2003-02-13

Family

ID=19065927

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/007773 WO2003012104A1 (en) 2001-08-01 2002-07-31 Novel g protein-coupled receptor protein and dna thereof

Country Status (2)

Country Link
JP (1) JP2003047472A (en)
WO (1) WO2003012104A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7972800B2 (en) 2003-04-25 2011-07-05 Takeda Pharmaceutical Company Limited Screening method for binding property or signal transduction alterations

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4542810B2 (en) * 2003-04-25 2010-09-15 武田薬品工業株式会社 New screening method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0887407A2 (en) * 1997-06-11 1998-12-30 Smithkline Beecham Corporation cDNA clone HAPO167 that encodes a human 7-transmembrane receptor
WO2001009328A1 (en) * 1999-08-03 2001-02-08 Millennium Pharmaceuticals, Inc. 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0887407A2 (en) * 1997-06-11 1998-12-30 Smithkline Beecham Corporation cDNA clone HAPO167 that encodes a human 7-transmembrane receptor
WO2001009328A1 (en) * 1999-08-03 2001-02-08 Millennium Pharmaceuticals, Inc. 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NAGASE T. ET AL.: "Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro", DNA RES., vol. 7, no. 2, 28 April 2000 (2000-04-28), pages 143 - 150, XP008010899 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7972800B2 (en) 2003-04-25 2011-07-05 Takeda Pharmaceutical Company Limited Screening method for binding property or signal transduction alterations

Also Published As

Publication number Publication date
JP2003047472A (en) 2003-02-18

Similar Documents

Publication Publication Date Title
WO2002084286A1 (en) Screening method
WO2006131659A3 (en) Fast binder compositions for concrete parts and works containing a calcium salt
DK2784084T4 (en) Antagonist antibodies against IL-17A/F heterologous polypeptides
PL376993A1 (en) Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
MXPA03008944A (en) 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors.
WO2002044368A1 (en) Novel g protein-coupled receptor proteins and dnas thereof
WO2003012104A1 (en) Novel g protein-coupled receptor protein and dna thereof
AU2003242106A1 (en) Detection kit, assay plate to be used therein, detection method, evaluation method, polyclonal antibody of frog vitellogenin and procss for producing the same
WO2002004624A9 (en) Novel g protein-coupled receptor protein and dna thereof
DE50206910D1 (en) SUBSTITUTED Y-LACTON COMPOUNDS AS NMDA ANTAGONISTS
IL150824A0 (en) Screening method
WO2002060948A1 (en) Novel g protein-coupled receptor protein and dna thereof
ATE497947T1 (en) NEW 1,3-DISUBSTITUTED AZETIDED DERIVATIVES FOR USE AS LIGANDS OF THE 5HT2A RECEPTOR
EP1619499A4 (en) Novel screening method
WO2003082320A1 (en) Novel screening method
WO2002061075A1 (en) Novel g protein-coupled receptor protein and dna thereof
EP1584925A4 (en) Novel screening method
WO2002083938A3 (en) Screening methods for identifying ligands
AU2003242311A1 (en) Composition for aldehyde detection
GB0328892D0 (en) Positive signal assay for analytes
AU2002220526A1 (en) Method of identifying compounds capable of acting as agonists or antagonists of g-protein coupled receptors
WO2003008445A1 (en) Novel g protein-coupled receptor protein and dna thereof
EP1572913A4 (en) Methods for the identification of novel ligands for the g protein-coupled receptor (gpcr) 192
WO2004027427A8 (en) Assays for fprl-1 ligands
FR2845348B1 (en) PENDULAR PIN SYSTEM, FOR BOAT ESPECIALLY SAILBOAT

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS KE KG KR KZ LC LR LS LT LU LV MA MD MG MK MN MX MZ NO NZ OM PH PL PT RO RU SE SG SI SK SL TJ TM TN TR TT TZ UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase